Caris Life Sciences
Highly Engaged Employees
Business Services · Texas, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
750 W John Carpenter Fwy Ste 800, Irving...Phone Number
(866) 771-8946Website
www.carislifesciences.comRevenue
$907.3 MillionStock Symbol
CAIIndustry
About Caris Life Sciences
Caris Life Sciences Org Chart
Senior Vice President, Chief Operations Offic...
Senior Vice President
Vice President, Clinical Programs
Vice President, Operations
Vice President, Genetic Operations
Corporate Vice President, Strategy & Operatio...
Corporate Vice President - Oncology Franchise
Head Vice President, Diagnostic Partnering, P...
Vice President, Clinical & Translational Rese...
Is Caris Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Caris Life Sciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Caris Life Sciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Caris Life Sciences
Earning: See what the market has to say on Caris Life Sciences recently announced quarterly report
Check if Caris Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Caris Life Sciences launches new products
Caris Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Caris Life Sciences has new funding data
Recommended Actions
Reach out to Masked Content who joined Caris Life Sciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Caris Life Sciences
Compare insights from companies similar to Caris Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Caris Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Caris Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Caris Life Sciences.
Caris Life Sciences financials insights
Gather financial insights about Caris Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Unspecified
$150M
Unspecified
$310M
Other Financing Round
$830M
Debt
$400M
Other Financing Round
$168M
IPO
$494M
Debt
$1.2B
Caris Life Sciences Tech Stack
A closer look at the technologies used by Caris Life Sciences
Most Recent Scoops
Caris Life Sciences News & Media
Caris Life Sciences Q2 Earnings Call Highlights
Caris Life Sciences (NASDAQ:CAI) reported record clinical volume and raised its full-year revenue outlook after second-quarter revenue increased 45% from a year earlier, driven by growth in molecular profiling services, higher average selling prices and an expanding commercial organization. The comCaris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Revenue growth of 45% driven by strong performance in molecular profiling services, including approximately 59,200 clinical cases, consisting of over 114,000 whole exome/whole transcriptome tests with over 345,000 total oncology tests Raises 2026 revenue guidance to $1.03 to $1.04...Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
IRVING, Texas, July 16, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced it will report second quarter 2026 financial results on Wednesday, August 5, 2026. Caris Life Sciences will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to...Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
IRVING, Texas, July 14, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced it will offer in-house PTEN immunohistochemistry (IHC) testing following the recent FDA approval of...
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Caris Life Sciences
Caris was founded in 2008 with a simple but powerful purpose to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of data, we are trailblazing the path to precision medicine by providing physicians and patients with the highest quality information about disease.... Read More
